Department of Nursing, Faculty of Health Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.
Department of Urology, Eskisehir City Hospital, Eskisehir, Turkey.
Int J Clin Pract. 2021 Mar;75(3):e13923. doi: 10.1111/ijcp.13923. Epub 2020 Dec 27.
To investigate the effect of COVID-19 on sexual dysfunction in women.
The women diagnosed with COVID-19 and hospitalised at a tertiary hospital were included. They completed the Introductory Data Form, the Female Sexual Function Index-(FSFI) and the Short Form-36 Quality of Life Scale (SF-36).
Fifteen women between the ages of 19-49 who completed the treatment protocol, discharged at least 14 days before and who had not been diagnosed as sexual dysfunction; sexually active earlier were included in the study. It was detected that weekly sexual intercourse before and after COVID-19 significantly differed (P = .047). The frequency of relationships decreased statistically after COVID-19. The mean value of the FSFI satisfaction score differs from COVID-19 before and after diagnosis (P = .012). The mean satisfaction score before COVID-19 was 3.47, and after COVID-19 was 2.93. The score of the subgroups of FSFI did not differ from COVID-19 before and after diagnosis (P > .050). The median value of SF-36 pain differs from COVID-19 before and after diagnosis (P = .008).
It was concluded that the frequency of sexual intercourse and sexual satisfaction in women decreased after COVID-19 disease, and the quality of life scores did not change in a statistically significant way.
调查 COVID-19 对女性性功能障碍的影响。
纳入在一家三级医院住院的确诊 COVID-19 的女性。她们填写了简介数据表、女性性功能指数-(FSFI)和 36 项简短健康调查问卷(SF-36)。
15 名年龄在 19-49 岁之间、完成治疗方案、至少在 COVID-19 出院前 14 天出院且未被诊断为性功能障碍的、有过性生活的女性被纳入研究。发现 COVID-19 前后每周性生活的频率有显著差异（P=0.047）。COVID-19 后性生活的频率呈统计学下降。FSFI 满意度评分的平均值与 COVID-19 前后诊断存在差异（P=0.012）。COVID-19 前的满意度评分为 3.47，COVID-19 后的满意度评分为 2.93。FSFI 亚组的评分与 COVID-19 前后诊断无差异（P>.050）。SF-36 疼痛的中位数与 COVID-19 前后诊断存在差异（P=0.008）。
COVID-19 后，女性的性生活频率和性满意度下降，生活质量评分无统计学意义的变化。
